The Health Ministry’s decision to raise the prices of some medications last year failed to prevent future shortages of key meds, Mohamed Mostafa writes for Al Borsa. The ministry had promised that it would allow another wave of price increases later in the year to encourage manufacturers to stick it out and continue producing. Since the second phase never came, pharma companies are incurring losses, while citizens have consistently been told that certain medications are in short supply or completely missing from the market.
More from Enterprise
The National Bank of Egypt and Banque Misr just hiked rates on CDs — moves that could see the EGP gain against the USD
NBE and BM both hiked rates on CDs by 125…
Qatar’s Green Sky Capital secures financing for USD 200 mn SAF plant
The facility could add more than 10% to global SAF…
EGX30 erases March losses with 14.2% April surge
The rally piled on roughly EGP 433 bn in market…
Kiwe gets Central Bank green light to launch nationwide
The startup is backed by our friends at EFG Hermes,…